chartexchange

XFOR
X4 Pharmaceuticals, Inc. Common Stock
stockNASDAQ

Market OpenNov 19, 2026 2:49:19 PM EST
2.95USD-1.007%(-0.03)820,477
2.9500Bid2.9600Ask0.0100Spread
Loading…
Loading…
301.75M
Healthcare
Biotechnology
HQ
Boston, MA, USA
Previous Close
$2.98
Beta
1.58
52-Week High
$4.83 2026-03-10
52-Week Low
$2.43 2026-10-14
SMA 50
$3.11
SMA 200
$3.76
Avg. Vol 10D
836,400
Avg. Vol 30D
723,157
Avg. Vol 90D
805,978
Relative Vol
1.13
102.11M
60.23M
0.4600%
Apr 28, 2025 · 1-for-30 (reverse)
XFOR Profile

x4 pharmaceuticals is developing novel therapeutics designed to improve immune cell trafficking and reverse immune suppression, which is fundamental to treating cancer and certain rare, genetic primary immunodeficiency diseases. our oral, small molecule drug candidates inhibit the binding of chemokine cxcl12 to c-x-c receptor type 4 (cxcr4), a receptor-ligand pair that plays an essential role in normal immune surveillance. we are committed to advancing the fields of cancer immunotherapy and genetic immune disorders through innovation and investment in our proprietary clinical and preclinical pipeline. x4's most advanced product candidate, x4p-001-rd, is in a phase 2/3 study in patients with whim syndrome, a rare genetic, primary immunodeficiency disease. x4p-001-io is currently under investigation in multiple phase 1/2 studies in refractory clear cell renal cell carcinoma (ccrcc) and melanoma. our third program, x4p-002, is in preclinical development and designed specifically for the t

XFOR Performance
PeriodPriceDateChangeBeta
1W3.172026-11-12-6.78%3.213
1M2.752026-10-19+7.46%1.173
3M4.162026-08-19-28.97%1.375
6M3.642026-05-19-18.82%1.526
1Y3.652025-11-19-19.04%1.581
2Y11.042024-11-19-73.23%—
5Y143.402021-11-19-97.94%1.308
XFOR Stock Summary

X4 Pharmaceuticals, Inc. Common Stock (NASDAQ:XFOR) stock price today is $2.96, and today's volume is 820,350. XFOR is down 0.839% today. The 30 day average volume is 723,157. XFOR market cap is $301.75M with 102.11M shares outstanding.